Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
Nat Struct Mol Biol. 2011 Apr;18(4):416-22. doi: 10.1038/nsmb.2028. Epub 2011 Mar 13.
High-density lipoproteins (HDLs) mediate cholesterol transport and protection from cardiovascular disease. Although synthetic HDLs have been studied for 30 years, the structures of human plasma-derived HDL and its major protein apolipoprotein apoA-I are unknown. We separated normal human HDL into five density subfractions and then further isolated those containing predominantly apoA-I (LpA-I). Using cross-linking chemistry and mass spectrometry, we found that apoA-I adopts a structural framework in these particles that closely mirrors that in synthetic HDL. We adapted established structures for synthetic HDL to generate the first detailed models of authentic human plasma HDL in which apoA-I adopts a symmetrical cage-like structure. The models suggest that HDL particle size is modulated by means of a twisting motion of the resident apoA-I molecules. This understanding offers insights into how apoA-I structure modulates HDL function and its interactions with other apolipoproteins.
高密度脂蛋白(HDL)介导胆固醇的转运,并预防心血管疾病。尽管已经对合成高密度脂蛋白进行了 30 年的研究,但人类血浆源性高密度脂蛋白及其主要蛋白载脂蛋白 A-I 的结构仍不清楚。我们将正常人的高密度脂蛋白分离成五个密度亚组分,然后进一步分离出主要含有载脂蛋白 A-I(LpA-I)的部分。使用交联化学和质谱法,我们发现载脂蛋白 A-I 在这些颗粒中采用了一种与合成高密度脂蛋白非常相似的结构框架。我们采用已建立的合成高密度脂蛋白结构,生成了第一个详细的真实人体血浆高密度脂蛋白模型,其中载脂蛋白 A-I 采用对称笼状结构。这些模型表明,通过 resident apoA-I 分子的扭曲运动来调节 HDL 颗粒的大小。这种理解为载脂蛋白 A-I 结构如何调节 HDL 功能及其与其他载脂蛋白的相互作用提供了新的思路。
Nat Struct Mol Biol. 2011-3-13
Proc Natl Acad Sci U S A. 2008-8-26
Biochemistry. 2010-11-23
Cell Mol Life Sci. 2001-6
Atheroscler Plus. 2025-2-25
Rev Cardiovasc Med. 2025-1-13
Antioxidants (Basel). 2024-6-28
Biochemistry. 2009-12-1
J Biol Chem. 2009-10-7
Arterioscler Thromb Vasc Biol. 2009-6